FREE Case Review (866) 588-0600

Zofran Heart Defects Lawsuit Filed in Louisiana

A Louisiana couple has filed a lawsuit against GlaxoSmithKline, the manufacturer of Zofran, alleging that the medication taken during pregnancy was responsible for the development of cardiac heart defects in their daughters.

A couple from Montegut, Louisiana, has filed a product liability lawsuit against GlaxoSmithKline (GSK) alleging that the anti-nausea medication Zofran caused their 2 daughters to be born with cardiac heart defects.

Free Confidential Lawsuit Evaluation: If your child was harmed by Zofran side effects, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer and our lawyers can help.

Update: Louisiana Couple Alleges Son’s Birth Defects from Zofran

April 14, 2016 – Another Louisiana couple has filed a product liability lawsuit against GSK alleging that its wrongful conduct and fraudulent misrepresentation regarding Zofran caused their child to be born with severe heart defects. After taking Zofran as directed during her first trimester of pregnancy, the woman gave birth to a baby boy with an enlarged right ventricle and pulmonary atresia, according to the lawsuit. Plaintiffs are demanding a jury trial and compensation for medical expenses, pain and suffering, and punitive damages.

What’s the problem?

March 25, 2016 – Hundreds of lawsuits have been filed against GSK alleging that Zofran caused birth defects; however, this case is unique in that the plaintiffs are claiming they had 2 daughters — born within a year of each other — and both were born with heart defects caused by Zofran exposure in the womb.

The complaint was initially filed March 3 in the U.S. District Court for the Eastern District of Louisiana under case number 2:16-cv-01806. Since being transferred to the Zofran multidistrict litigation in Boston, the case has been filed under number 1:16-cv-10544-FDS.

A pair of recent studies, performed in Denmark and Sweden, have found evidence that fetuses exposed to Zofran during the 1st trimester of pregnancy have an increased risk of being born with congenital heart abnormalities. In one study, which looked at Danish birth records from more than 900,000 pregnancies, researchers found that babies exposed to Zofran in the womb were between 2 and 4 times more likely to be delivered with cardiac septal (“hole in the heart”) defects.

In recent years, Zofran has become increasingly prescribed “off-label” to pregnant women with morning sickness. The drug has never received approval from the U.S. Food & Drug Administration (FDA) for this use. It is legal for doctors to prescribe medications off-label when they feel the potential benefits outweigh the risks; however, lawsuits allege that despite lacking approval, GSK unlawfully promoted Zofran for use during pregnancy, even paying kickbacks to doctors who prescribed large quantities of the medicine.

Do I Have a Zofran Lawsuit?

The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Zofran lawsuits. We are handling individual litigation nationwide and currently investigating potential payouts in all 50 states.

Free Confidential Case Evaluation: Again, if your child or other loved one was born with a defect you feel may have been caused by Zofran exposure, you should contact our law firm immediately. You may be entitled to a settlement by filing a lawsuit we can help.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
*
*
*

Awards & recognition